Start from a proven base
Our own formulations, developed and owned by us, already moving through Korean pharmacy counters and clinic treatment rooms. You adapt rather than invent.
K-beauty OEM / ODM
AIM Global is a Korean OEM/ODM partner that puts your brand on formulations we own and already supply to Korean beauty brands — instead of starting from a blank brief and a catalogue of generic bases.
Those are two different projects. One is development work with an unknown outcome. The other is a base with a track record for the Korean beauty Brands, adapted to your market and your brand.
Our own formulations, developed and owned by us, already moving through Korean pharmacy counters and clinic treatment rooms. You adapt rather than invent.
Manufacturing runs in Korea under our own supply agreements, with the batch documentation an importer expects.
For several lines we grant exclusivity in a territory, so the product you build a market for does not appear beside you at a lower price.
/ 02 What we produce
These are the categories we distribute in Korea, which is also the range we can produce under your brand. The channel that validates the formulation and the line that manufactures it are the same.
Ceramide barrier systems, atopic and sensitive-skin lines, medical-grade suncare, and post-acne repair — bases built for the pharmacy counter rather than the trend cycle.
Post-procedure soothing, PDRN and peptide ampoules, high-dose vitamin C, and peel systems. Higher active levels, and claims a clinic is willing to stand behind.
Barrier repair, redness and rosacea care, and post-treatment recovery, with human application testing behind the claims.
Lines formulated with human stem-cell conditioned media and related biotechnology actives. Ingredient status is confirmed per destination market before anything is quoted.
Your brand, your packaging, our formulation and production. OEM where you bring the specification, ODM where you bring the positioning and we bring the formulation.
/ 03 Formulation
A private-label base is only worth having if the work behind it survives a buyer's questions.
Barrier science — ceramide ratios matched to the skin's own lipid profile, pH-balanced systems, and irritation testing designed for compromised and post-procedure skin.
Biotechnology-derived actives — PDRN, peptide complexes, and fermented ingredients produced under controlled bioprocess rather than simple plant extraction.
Substantiation — human application testing, dermatologist-supervised evaluation, and efficacy data that transfers into your own marketing claims where your market allows it.
/ 05 How a project runs
Your market, your channel, the price point you need to hit, and the claim you want to own. That decides which of our bases is a candidate and which are not.
We come back with the bases that fit, what each one supports as a claim, and indicative minimums and pricing. Minimums and lead times depend on the formulation and the packaging, so they arrive per option rather than as one number.
Samples of the shortlisted bases, plus a check of the ingredient list against your destination market's rules. We tell you early which bases are straightforward in your market and which are not.
Your packaging and artwork against the base you chose, with the mandatory label content for your market. Nothing goes to production before you sign off on a physical sample.
Production in Korea, batch documentation, and export from our Seoul hub — the same consolidation, batch and expiry checks, and paperwork as our distribution orders.
Beyond production
The reason our bases are worth private-labelling is that we sell them ourselves. AIM Global is a primary vendor to pharmacies and dermatology clinics across Korea, including the districts foreign visitors shop in. If you would rather import finished Korean products before committing to your own brand, that route is open too.
/ 07 Coverage
One hub in Seoul, consolidated shipments, and routes chosen for your cost-to-speed priority.
/ 08 FAQ
OEM is where you bring the specification and we produce it. ODM is where you bring the positioning and the price point, and we propose the formulation from the bases we own. Most projects start as ODM and narrow into OEM once a base is chosen.
They depend on the formulation and the packaging you choose, so a single number would be misleading. They come with the base shortlist, per option, after you tell us your market and price point.
For several lines, yes. Exclusivity is possible because the formulations are ours rather than licensed. What is open depends on the line and the territory — tell us your market and the channel you reach and we will say.
We supply the document set an importer normally needs — ingredient breakdown, certificates of analysis, free-sale certificates, and product specifications. The registration filing itself is made by the licence holder in your country. We screen the ingredient list against your market's rules before you commit, so surprises come up early rather than at customs.
Either. Tell us which you intend at the briefing stage, because it changes both the minimums and the timeline. Nothing goes to production until you have approved a physical sample.
In most markets, with care about how it is phrased. Advertising rules differ, and a claim that is fine in one market is a regulatory problem in another. We give you what is factually true about the base and its Korean channel; how far you can go with it is a question for your market.
Yes. The same formulations are available as finished goods through our distribution business, which is often the better first step — it proves the demand before you pay for packaging and minimums.
Over 100 countries by air, ocean, and road from our Seoul hub. A base shortlist with indicative terms comes back within 48 hours for most enquiries; projects involving a new formulation or regulatory screening take longer, and we will tell you when to expect them. We operate under Korean export regulation and do not ship to sanctioned countries or regions.
/ 09 Talk to us
Your market, your channel, and the price point you need to hit is enough to start. We come back with the bases that fit, what each one supports as a claim, and indicative terms — usually within 48 hours.